Gastrointestinal Endoscopy
Volume 71, Issue 4 , Pages 704-705 , April 2010

Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus

References 

  1. Inoue H, Endo M, Takeshita K, et al. A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope. Surg Endosc. 1992;6:264–265
  2. Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut. 2008;57:1200–1206
  3. Pouw RE, Gondrie JJ, Sondermeijer CM, et al. Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg. 2008;12:1627–1637
  4. Prasad GA, Wu TT, Wigle DA, et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology. 2009;137:815–823
  5. Badreddine RJ, Prasad GA, Wang KK, et al. Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus. Gastrointest Endosc. 2010;71:697–703

PII: S0016-5107(09)02893-4

doi: 10.1016/j.gie.2009.12.027

Gastrointestinal Endoscopy
Volume 71, Issue 4 , Pages 704-705 , April 2010